Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Geriatrie Et Psychologie Neuropsychiatrie Du Vieillissement|September 24, 2014
[The elderly in radiotherapy: myths and prospects]Aurore Goineau, Loïc Campion, Marc-André Mahé
Frontiers in Oncology|November 4, 2015
Integrating Geriatric Assessment into Decision-Making after Prostatectomy: Adjuvant Radiotherapy, Salvage Radiotherapy, or None?Aurore Goineau, Bénédicte d'Aillières, Laure de Decker, et al.
Clinical Nuclear Medicine|May 29, 2015
Incidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18F-FDG in a Patient With Prostate CancerAurore Goineau, Mathilde Colombié, Caroline Rousseau, et al.
Brachytherapy|December 3, 2014
Postoperative interstitial brachytherapy for resectable squamous cell carcinoma of the tongueAurore Goineau, Benoit Piot, Olivier Malard, et al.
Radiation Oncology (London, England)|March 21, 2013
Prospective evaluation of quality of life 54 months after high-dose intensity-modulated radiotherapy for localized prostate cancerAurore Goineau, Virginie Marchand, Jérome Rigaud, et al.
Cancers|March 19, 2020
Can Comprehensive Geriatric Assessment Predict Tolerance of Radiotherapy for Localized Prostate Cancer in Men Aged 75 Years or Older?Aurore Goineau, Loïc Campion, Jean-Marie Commer, et al.
International Journal of Radiation Oncology, Biology, Physics|December 18, 2018
Early Toxicity of a Phase 2 Trial of Combined Salvage Radiation Therapy and Hormone Therapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer (OLIGOPELVIS GETUG P07)Loig Vaugier, Clément Palpacuer, Emmanuel Rio, et al.
Plos One|April 10, 2018
Comprehensive Geriatric Assessment and quality of life after localized prostate cancer radiotherapy in elderly patientsAurore Goineau, Loïc Campion, Bénédicte d'Aillières, et al.
Lancet (London, England)|March 7, 2026
5-year results of hypofractionated locoregional radiotherapy in early breast cancer HypoG-01 (UNICANCER): a French multicentre, randomised, non-inferiority, phase 3, open-label, controlled trialSofia Rivera, Robabeh Ghodssighassemabadi, Guillaume Auzac, et al.
The Lancet. Healthy Longevity|February 19, 2026
Hypofractionated split-course versus standard radiotherapy in frail older patients with head and neck squamous-cell carcinoma (ELAN-RT trial): a non-inferiority, multicentre, open-label, randomised controlled trialCécile Ortholan, Anne Aupérin, Yungan Tao, et al.
Pageof 1